cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Athenex Inc
18 own
31 watching
Current Price
$0.19
$0.01
(4.49%)
logo-atnx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
29.28M
52-Week High
52-Week High
1.2
52-Week Low
52-Week Low
0.1184
Average Volume
Average Volume
0.83M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization29.28M
icon52-Week High1.2
icon52-Week Low0.1184
iconAverage Volume0.83M
iconDividend Yield--
iconP/E Ratio--
What does the Athenex Inc do?
N/A
Read More
How much money does Athenex Inc make?
News & Events about Athenex Inc.
Globe Newswire
24days ago
MHRA denies Oral Paclitaxel for metastatic breast cancer based solely on chemistry, manufacturing and control (CMC) issuesAthenex plans to request a review of the MHRA decision by an independent panel The MHRA application was supplemented with safety data from the iSPY 2 study and no major clinical ...
PR Newswire
1month ago
Thinking about buying stock in Athenex, Camber Energy, Mullen Automotive, Iamgold, or United States Steel? Thinking about buying stock in Athenex, Camber Energy, Mullen Automotive, Iamgold, or United States Steel? PR Newswire NEW YORK, Dec. 20, 2022 NEW YORK, Dec. 20, 2022 /PRNewswire...
Globe Newswire
1month ago
Oral Paclitaxel combination regimen has graduated in this Phase 2 trial in the triple negative breast cancer subgroupBUFFALO, N.Y., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of ...
Globe Newswire
1month ago
Full-year 2022 product sales guidance maintained at 20-25% growth year-over-yearBUFFALO, N.Y., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of ...
Globe Newswire
2 months ago
Shareholders voted in favor of all three proposals submitted before the Special Stockholder Meeting BUFFALO, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for...
Frequently Asked Questions
Frequently Asked Questions
What is Athenex Inc share price today?
plus_minus_icon
Can Indians buy Athenex Inc shares?
plus_minus_icon
How can I buy Athenex Inc shares from India?
plus_minus_icon
Can Fractional shares of Athenex Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Athenex Inc stocks?
plus_minus_icon
What is today’s traded volume of Athenex Inc?
plus_minus_icon
What is today’s market capitalisation of Athenex Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Athenex Inc?
plus_minus_icon
What percentage is Athenex Inc down from its 52-Week High?
plus_minus_icon
What percentage is Athenex Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.19
$0.01
(4.49%)
logo-atnx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00